Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1942 of 5804
-
Can a cancer drug turn back the clock on aging?
Disease control OngoingThe objective of this project is to determine if mTORC1 inhibition by 24 weeks of daily (0.5 mg/day) or weekly (5 mg/week) everolimus can safely improve physiological and molecular hallmarks of aging in humans. Participants who are 55-80 years old and insulin resistant or prediab…
Phase: PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Lung cancer drug trial halted early: what we know
Disease control TerminatedThis is a Phase I open label multi-center study to evaluate the safety, tolerability, pharmacokinetics and preliminary effectiveness of the investigational drug MYTX-011 in patients with locally advanced, recurrent or metastatic NSCLC. MYTX-011 is in a class of medications called…
Phase: PHASE1 • Sponsor: Mythic Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New pill could quiet chronic cough in adults
Symptom relief CompletedThis Phase IIa, multicenter, randomized, double-blind, placebo-controlled, crossover study will evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamic (PD) effects of GDC-6599 compared with placebo in patients with a history of chronic cough.
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New drug shows promise for blistering skin disease in extended trial
Disease control TerminatedThe purpose of this study is to evaluate the safety of efgartigimod PH20 SC over a longer period of time in adult participants with moderate-to-severe bullous pemphigoid (BP) who have completed ARGX-113-2009 study. The study will also evaluate the efficacy of efgartigimod PH20 SC…
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Horse therapy shows promise for autism Self-Control
Symptom relief CompletedThe goal of this clinical trial is to learn about occupational therapy integrating horses for autistic youth. The main questions it aims to answer are: * Does occupational therapy integrating horses improve self-regulation in autistic youth * Does occupational therapy integratin…
Phase: NA • Sponsor: Colorado State University • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Could a gut supplement ease autism symptoms? new trial investigates
Symptom relief Recruiting nowRecent research links gut microbiota alterations to Autism Spectrum Disorders (ASD), a neurobiological condition with multifactorial bases. In some ASD patients, altered gut flora and increased intestinal permeability are observed, influencing the central nervous system's develop…
Phase: PHASE2, PHASE3 • Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
Your phone could predict your health: new study tracks childhood cancer survivors
Knowledge-focused OngoingSome childhood cancer survivors have health problems as the result of previous cancer treatment. This study is being done to determine if we can better predict the risk a childhood cancer survivor might have for developing future health issues. The goal of this study is to enabl…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New study aims to bring early psychosis care to community clinics
Knowledge-focused Recruiting nowThis is a dissemination and implementation study that is evaluating a stepped-care intervention for identifying and treating youths at clinical high-risk for psychosis within multiple community mental health centers.
Phase: NA • Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
AI spots broken bones better than doctors alone?
Diagnosis CompletedThis retrospective study aims to evaluate the effectiveness of artificial intelligence (AI) in identifying fractures on musculoskeletal X-rays. By comparing the performance of a deep learning AI model with that of experienced radiologists, we seek to understand how AI can help im…
Sponsor: Carebot s.r.o. • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
New program aims to cut teen sexual assault by half
Knowledge-focused CompletedSexual violence (SV) perpetrated by dating partners and male acquaintances is common among adolescent girls in high school. Girls and young women who experience SV are likely to encounter negative mental and physical health consequences as well as lowered academic performance. Wh…
Phase: NA • Sponsor: University of Windsor • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Smart software aims to improve repeat heart ablation for AFib
Disease control CompletedMulti-center, international, non-randomized clinical trial evaluating the use of Volta's VX1 algorithm as used in combination with repeat catheter ablation after AF recurrence after previous catheter ablation.
Phase: NA • Sponsor: Volta Medical • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
10-Year study tracks new device for aortic repair
Disease control OngoingThe goal of this observational study is to evaluate the Thoraflex Hybrid device alone and in combination with the RelayPro NBS stent-graft in the treatment of aortic disease affecting the aortic arch and descending aorta with or without involvement of the ascending aorta. Patien…
Sponsor: Vascutek Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Scientists probe why interferon works for some blood cancer patients but not others
Knowledge-focused Recruiting nowClassical BCR-ABL-negative myeloproliferative neoplasms (MPN) include: Polycythemia Vera (PV), Essential Thrombocythemia (ET) and Primary Myelofibrosis (PMF). They are myeloid malignancies resulting from the transformation of a multipotent hematopoietic stem cell (HSC) caused by …
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Can more radiation zap cancer pain faster?
Symptom relief Recruiting nowThe investigators hypothesize that with dose escalation to 40-50 Gy in ten fractions, the complete pain response rate at one month can be increased to 40-50% in painful non-spinal bone metastases. Additionally, the investigators hypothesize that utilizing a fractionation scheme w…
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Can early foster care boost a Child's brain and emotional growth?
Knowledge-focused Recruiting nowThe purpose of this study is to determine the effects of early intervention (placement into foster care, and a caregiving training) on physical, cognitive, social and brain development and psychiatric symptomatology in children place in out-of-home care.
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Could a switch to analogue insulin reduce dangerous low blood sugar in kids with diabetes?
Disease control CompletedThe primary objective of this trial is to determine whether insulin glargine reduces the risk of serious hypoglycemia or improves Time in Range at 6 months when compared against standard of care human insulin (e.g. NPH or premixed 70/30) among youth living with type 1 diabetes (T…
Phase: PHASE4 • Sponsor: Jing Luo • Aim: Disease control
Last updated Jun 26, 2026 16:29 UTC
-
New cancer drug PRO1160 tested in advanced cancers – trial ends early
Disease control TerminatedBrief Summary: This study will test the safety, including side effects, and determine the characteristics of a drug called GEN1160 (PRO1160) in participants with solid tumors and blood cancers. Participants will have cancer that has spread through the body (metastatic) or canno…
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Which revision surgery works best for weight regain after sleeve gastrectomy?
Disease control Recruiting nowAssess what revisional surgery is superior and provides the best weight loss after primary LSG. What is the occurrence of complications and the nutritional laboratory status? And if the resolution and /or improvement of associated medical problems after the weight loss will occur…
Phase: NA • Sponsor: General Committee of Teaching Hospitals and Institutes, Egypt • Aim: Disease control
Last updated Jun 26, 2026 18:15 UTC
-
New shot shows promise for lowering bad cholesterol
Disease control CompletedCKJX839D12304 was a research study to determine if the study treatment, called inclisiran, in comparison to placebo and ezetimibe effectively reduces Low-Density Lipoprotein Cholesterol (LDL-C) as measured by percentage change from baseline to Day 150. This study was conducted in…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug combo shows promise for untreatable liver cancer
Disease control OngoingThe study will assess the safety of the association of NP137 with the standard of care Atezolizumab-Bevacizumab in first line setting in patients with unresectable hepatocellular carcinoma. The study drug which is tested is the NP137 in association with Atezolizumab-Bevacizumab t…
Phase: PHASE1 • Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC